This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The United States Pharmacopeial Convention (USP) announced that Bingbing Feng will become Vice President and General Manager of USP–China in Shanghai.
Feng will assume his new responsibilities as of March 30th.
According to Feng, “I’m pleased to be joining an organization whose mission is dedicated to improving public health by ensuring the quality, safety, and benefit of medicines and foods. China’s contribution to the global supply of medicines and food will become even more significant, and USP plays a critical part in protecting and enhancing the quality of those products for consumers in China and around the world.”
“USP’s current strategic outlook includes expanded outreach within China and the Asian region with regard to public health programs and quality-related initiatives,” said Ron Piervincenzi, Ph.D., USP’s Chief Executive Officer. “Dr. Feng’s strong background in leadership, management and business development coupled with his technical experience will play a strong role in shaping USP’s relationships with customers, government officials, professional and trade associations and other groups of interest in Asia moving forward.”
For 15 years, Dr. Feng has held various positions in the pharmaceutical and contract research organization (CRO) industries in both U.S. and China. Most recently, he served as Vice President of Business Development at Alliance Pharma, Inc., in Malvern, Pa. His previous industry positions have included leadership roles in operations, business development, global manufacturing and supply and R&D at Shanghai Medicilon, Inc. (Shanghai); Frontage Laboratories, Inc. (Exton, Pa., and Shanghai); Kelly Services at McNeil Consumer Healthcare (Johnson & Johnson) (Fort Washington, Pa.) and GlaxoSmithKline (King of Prussia, Pa.). Dr. Feng studied at University of Science and Technology of China, and received a Bachelor of Science degree in chemistry (minors in mathematics and physics) from James Madison University and a Ph.D. in analytical chemistry from Purdue University. He conducted postdoctoral research at Pacific Northwest National Laboratory.
Dr. Feng will be responsible for USP’s operations in China including all laboratory activities supporting USP’s standards-setting needs and other allied programs, with management oversight for approximately 75 staff. Established in 2007, USP’s China site completed a technical laboratory expansion in early 2014. USP also has global operations in Rockville, Md. (U.S.); Hyderabad, India and São Paulo, Brazil as well as sites in Basel, Switzerland; Accra, Ghana and Addis Ababa, Ethiopia.
>> For more information, click here
